Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Lung Cancer treatment details. Biologic therapy. Chemotherapy. Radiation. MD Anderson Cancer Center, Houston, TX, United States



Survival: 22.7 months
   
Toxicity Grade: 5
   
Treatments: Biologic therapy
Chemotherapy
Radiation
   
Drugs:
Country: United States
   
City/State/Province: Houston, TX
   
Hospital: MD Anderson Cancer Center
   
Journal: Link
   
Date: 6/2010

Description:
Patients:
This phase II study involved 87 patients with stage IIIA/B non-small cell lung cancer. Of these, the median age was 64 years and 57% were male.

Treatment:
Patients in this study were treated with the biologic therapy agent cetuximab and with chemoradiotherapy, which is a combination of radiation therapy and the chemotherapy agents paclitaxel and carboplatin.

Toxicities:
There were five treatment-related deaths reported for this study, causes of which included respiratory problems and infection.

Results:
The reported median overall survival was 22.7 months.

Support:
Some of the authors have received support from various pharmaceutical companies.

Correspondence: Dr. George R. Blumenschein Jr.; email: gblumens@mdanderson.org

E-mail to a Friend Email Physician More Information